Conference abstractPublished 19 Oct 2017
Systematical administration of Clostridium ghonii spores results in significant tumour regression and strong antitumour Th1 responses in TC-1 tumour bearing mice
Griffith University, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Up to 85% of solid cancers, once diagnosed, lost the opportunity to be operable. These cancers have anoxia regions that limit the effectiveness of conventional therapies, which however, provide a heaven for anaerobic bacteria. Our laboratory has adapted the spores of an extracellular Clostridium ghonii strain that caused targeted oncolysis by selectively germinating, multiplying and digesting away of the solid cancer extramatrics, cellular structure, and cancer cells, resulting in significant enhanced tumour regression. Other anaerobic bacteria also showed a Toll-like receptor 4-mediated an antitumor host response together with significant increases of intra-tumour IFNÃ?³, CXCL9 and CXCL10 levels as well as more infiltration of macrophages, neutrophils, CD4+ and CD8+ T cells in C3H/HeN mice. In this report, we exployed a HPV E7 transformed TC-1 cell tumour bearing mice as a model and demonstrated that intratumoural and/or introvenous administration of a strain of a deviriative of Clostridium ghonii (DCG) spore leads to a significant tumour regression and a tumour local pro-inflammatory response characterized with increased levels of IL-6, IL-17 and IFNÃ?³. IFNÃ?³ secreting T cells are also attracted to the tumour site. Low numbers of antigen specific T cells were elicited after DCG treatment are elicited by intravenous DCG treatment. The results suggested that both oncolytic effects and the anticancer immune respnses are contriuting to cancer regression. Furthermore, strategies for optimium combined oncolytic, ie.: oncotic therapy, if combined with a therapeutic vaccine, more antigen specific T cells may be attracted to the tumour site and therefore, may achieve better outcome for cancer treatment.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ming Q Wei”
- BylineArticles whose byline prints “Guoying Ni”
- BylineArticles whose byline prints “Xiaosong Liu”
- BylineArticles whose byline prints “David Good”
